Expert Recommendation for Novel Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in HIV-Infected Adults

作     者：AIDS and Hepatitis C Professional Group,Chinese Society of Infectious Diseases Taisheng Li Hongzhou Lu AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases

作者机构：不详 Department of Infectious DiseasesPeking Union Medical College HospitalChinese Academy of Medical Sciences Department of Infection and ImmunologyShanghai Public Health Clinical Center 

出 版 物：《Infectious Diseases & Immunity》 (感染性疾病与免疫（英文）)

年 卷 期：2021年第1卷第3期

页      面：133-136页

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1001[医学-基础医学(可授医学、理学学位)] 100103[医学-病原生物学] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：National Key Technologies R&D Program of China during the 13th Five-year Plan Period(2017ZX10202101) Medical Innovation Research Project of Science and Technology Innovation Action Plan of Shanghai Science and Technology Committee 2020(20Z11900900). 

主　　题：HIV infections Severe acute respiratory syndrome coronavirus 2 Vaccines 

摘      要：The outbreak of coronavirus disease 2019(COVID-19)caused by the novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has become a pandemic.SARS-CoV-2 vaccination is currently being actively promoted worldwide as a promising measure to combat the pandemic.However,human immunodeficiency virus(HIV)-infected individuals who manifest varying degrees of immunodeficiency and chronic inflammation may require special consideration with regards to vaccine types and the timing of immunization depending on specific clinical situations.The present recommendation provides a reference for SARS-CoV-2 vaccination in HIV-infected patients.